CTEC - Ticker AI Digest

ConvaTec Group PLC 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (CTEC) 1
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 2
CTEC 14:01
ConvaTec Group PLC
Holding(s) in Company
CTEC 09:01
ConvaTec Group PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
CTEC 06:01
ConvaTec Group PLC
Trading update for 10 months ended 31 October 2025
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Convatec Group PLC Trading Update for 10 Months Ended 31 October 2025**
Convatec Group PLC reported strong, broad-based organic revenue growth of **6.3%** (excluding InnovaMatrix®) for the ten months ended 31 October 2025, driven by successful new product launches and continued market share gains. Including InnovaMatrix®, growth was **5.0%**, with reported growth at **6.2%**. The company remains on track to meet its FY25 financial targets and expects another year of double-digit adjusted EPS growth in FY26, supported by **5-7%** organic growth in non-InnovaMatrix® sales.
**Key Highlights**
**Product Performance** New launches such as ConvaFoamâ„¢, Esteem Bodyâ„¢, and GentleCath Airâ„¢ for Women are gaining traction across Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care segments.
**Financial Outlook** FY25 organic revenue growth (excluding InnovaMatrix®) is revised to **6.0-6.5%** (from 5.5-7.0%), with InnovaMatrix® revenue expected at around **$70m**. Adjusted operating profit margin is maintained at **22.0-22.5%**, and double-digit adjusted EPS growth is reaffirmed.
**Medium-Term Targets** Convatec aims for **5-7%** organic revenue growth, double-digit adjusted EPS growth, and reaching a mid-20s% adjusted operating margin by 2026/2027.
**Strategic Progress** Secured a new US Ostomy GPO contract (Captis/Vizient), extended another contract, and advanced its innovation pipeline with upcoming launches like ConvaNioxâ„¢ and ConvaFiberâ„¢.
**Operational Updates** Completed **$202m** of its **$300m** share buyback program and issued a **$500m** investment-grade bond.
**InnovaMatrix® Update**
InnovaMatrix® revenues represented **~3%** of Group revenue in the period. Despite regulatory uncertainties, Convatec expects InnovaMatrix® revenue of **$70m** in FY25. The CMS revised payment rate for skin substitutes, effective January 2026, is estimated to create a **1-2%** Group revenue headwind.
**CEO Commentary**
Jonny Mason highlighted the resilience of Convatec’s business, driven by strong sales growth from new products and ongoing simplification initiatives. He emphasized the company’s commitment to patient care and its position to deliver financial targets.
**Conference Call**
A conference call with analysts and investors was scheduled for 08:30 GMT on 13 November 2025 to discuss the trading update.
**About Convatec**
Convatec is a global medical products company focused on chronic care solutions, with revenues exceeding **$2 billion** in 2024 and a presence in ~90 countries.
**Forward-Looking Statements**
The update includes forward-looking statements based on current estimates and assumptions, subject to business and economic uncertainties. No assurance is given regarding future results.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 26
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 14:01
ConvaTec Group PLC
Holding(s) in Company
CTEC 06:06
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Trading update for 10 months ended 31 October 2025
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Convatec Group PLC Trading Update for 10 Months Ended 31 October 2025**
Convatec Group PLC reported strong, broad-based organic revenue growth of **6.3%** (excluding InnovaMatrix®) for the ten months ended 31 October 2025, driven by successful new product launches and continued market share gains. Including InnovaMatrix®, growth was **5.0%**, with reported growth at **6.2%**. The company remains on track to meet its FY25 financial targets and expects another year of double-digit adjusted EPS growth in FY26, supported by **5-7%** organic growth in non-InnovaMatrix® sales.
**Key Highlights**
**Product Performance** New launches such as ConvaFoamâ„¢, Esteem Bodyâ„¢, and GentleCath Airâ„¢ for Women are gaining traction across Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care segments.
**Financial Outlook** FY25 organic revenue growth (excluding InnovaMatrix®) is revised to **6.0-6.5%** (from 5.5-7.0%), with InnovaMatrix® revenue expected at around **$70m**. Adjusted operating profit margin is maintained at **22.0-22.5%**, and double-digit adjusted EPS growth is reaffirmed.
**Medium-Term Targets** Convatec aims for **5-7%** organic revenue growth, double-digit adjusted EPS growth, and reaching a mid-20s% adjusted operating margin by 2026/2027.
**Strategic Progress** Secured a new US Ostomy GPO contract (Captis/Vizient), extended another contract, and advanced its innovation pipeline with upcoming launches like ConvaNioxâ„¢ and ConvaFiberâ„¢.
**Operational Updates** Completed **$202m** of its **$300m** share buyback program and issued a **$500m** investment-grade bond.
**InnovaMatrix® Update**
InnovaMatrix® revenues represented **~3%** of Group revenue in the period. Despite regulatory uncertainties, Convatec expects InnovaMatrix® revenue of **$70m** in FY25. The CMS revised payment rate for skin substitutes, effective January 2026, is estimated to create a **1-2%** Group revenue headwind.
**CEO Commentary**
Jonny Mason highlighted the resilience of Convatec’s business, driven by strong sales growth from new products and ongoing simplification initiatives. He emphasized the company’s commitment to patient care and its position to deliver financial targets.
**Conference Call**
A conference call with analysts and investors was scheduled for 08:30 GMT on 13 November 2025 to discuss the trading update.
**About Convatec**
Convatec is a global medical products company focused on chronic care solutions, with revenues exceeding **$2 billion** in 2024 and a presence in ~90 countries.
**Forward-Looking Statements**
The update includes forward-looking statements based on current estimates and assumptions, subject to business and economic uncertainties. No assurance is given regarding future results.
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:06
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
CEO and CFO appointments
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 10:20
ConvaTec Group PLC
Total Voting Rights
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 12:01
ConvaTec Group PLC
Convatec announces Karim Bitar has passed away
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 09:01
ConvaTec Group PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares
CTEC 06:01
ConvaTec Group PLC
Transaction in Own Shares

AI Crunch

Single-Ticker AI Crunch
CTEC signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for ConvaTec Group PLC. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full CTEC AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for CTEC on 2025-11-19.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
4730557952
Enterprise Value
5708861811
Public Float
99.14
Broker Target
303.3045
Shares Out
1954454579
Long Interest
88
Short Interest
12
Exchange
LSE
Currency Code
GBX
ISIN
GB00BD3VFW73
Market
LSE - MAIN MARKET
Sector
Medical Equipment and Services
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.05
Ex Divi
2026-04-16
Earnings Date
2026-02-24
Net Debt
1537559926.0
Cash
75027321.0
EPS
0.06
Net Income
178671552.0
Revenue
2490170962.0
Enterprise Value
5708861811
Trailing PE
40.34
Forward PE
15.8479
Price Sales TTM
1.9395
Price Book MRQ
4.1414
EV Revenue
3.1721
EV EBITDA
14.9935

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
28.567
Institutions As Of
2026-02-06
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
5
Purchase TR1
7
Sale TR1
6
Broker Coverage Rows
23
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit CTEC.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-11-19 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
ConvaTec Group PLC has fresh news flow feeding the chart narrative.
06:01 Today's Catalyst Transaction in Own Shares
AI Charts Studio
CTEC Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-11-19 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 1.85%
RSI Gauge
Price Change
AI Forecast